Achieving target cholesterol goals after stroke: is in-hospital statin initiation the key?

Nerses Sanossian1, Jeffrey L Saver, David S Liebeskind

  • 1Stroke Center and Department of Neurology, Olive View Medical Center, University of California-Los Angeles, 710 Westwood Plaza, Los Angeles, CA 90095, USA. nsanossian@mednet.ucla.edu

Archives of Neurology
|August 16, 2006
PubMed

Insights

Initiating statin therapy during hospitalization for ischemic stroke significantly improves patient adherence to treatment and helps achieve cholesterol goals. This approach is vital for secondary vascular disease prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • National guidelines recommend statin therapy for secondary prevention in atherosclerotic ischemic stroke or transient ischemic attack.
  • Statins are proven beneficial for individuals at high risk of vascular disease.

Purpose of the Study:

  • To assess the impact of initiating statin therapy during hospitalization on 3-month adherence rates.
  • To determine if in-hospital statin initiation helps achieve national cholesterol target goals.

Main Methods:

  • Consecutive patients admitted with ischemic stroke or transient ischemic attack between September 2002 and April 2005 were analyzed.
  • Patients not on statins pre-admission but with a clear indication were included.
  • Statin adherence and cholesterol levels were evaluated at 3 months post-discharge.

Main Results:

  • Hospital initiation of statins resulted in 93% adherence at 3 months.
  • Mean low-density lipoprotein cholesterol decreased from 120 mg/dL to 78 mg/dL (P<.001).
  • The proportion of patients achieving <100 mg/dL low-density lipoprotein cholesterol increased from 36% to 88% (P<.001).

Conclusions:

  • Initiating statin therapy during hospitalization for ischemic cerebrovascular events leads to high adherence.
  • This strategy effectively lowers low-density lipoprotein cholesterol levels.
  • In-hospital statin initiation increases the likelihood of meeting national cholesterol guidelines.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...